Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$13.52
-0.1%
$13.23
$11.82
$28.00
$9.19B1.048.32 million shs294 shs
Bruker Corporation stock logo
BRKR
Bruker
$41.25
-1.3%
$38.52
$34.10
$72.94
$6.25B1.162.16 million shs233 shs
Revvity, Inc. stock logo
PKI
Revvity
$127.73
$113.46
$170.00
$14.57B1.1851,117 shs1.63 million shs
10x Genomics stock logo
TXG
10x Genomics
$11.83
+0.9%
$9.37
$6.78
$24.76
$1.44B1.992.68 million shs4,229 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
0.00%-0.21%+4.93%-16.56%-36.10%
Bruker Corporation stock logo
BRKR
Bruker
0.00%+9.77%+14.11%+0.14%-34.49%
Revvity, Inc. stock logo
PKI
Revvity
0.00%0.00%0.00%0.00%0.00%
10x Genomics stock logo
TXG
10x Genomics
0.00%+8.51%+23.60%+34.36%-39.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avantor, Inc. stock logo
AVTR
Avantor
4.9608 of 5 stars
4.25.00.03.22.23.32.5
Bruker Corporation stock logo
BRKR
Bruker
4.9024 of 5 stars
4.21.01.73.81.85.01.9
Revvity, Inc. stock logo
PKI
Revvity
3.9499 of 5 stars
0.00.01.73.51.11.74.4
10x Genomics stock logo
TXG
10x Genomics
4.8084 of 5 stars
4.24.00.04.82.13.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
2.46
Hold$18.8839.34% Upside
Bruker Corporation stock logo
BRKR
Bruker
2.40
Hold$52.8926.53% Upside
Revvity, Inc. stock logo
PKI
Revvity
0.00
N/AN/AN/A
10x Genomics stock logo
TXG
10x Genomics
2.43
Hold$14.9627.55% Upside

Current Analyst Ratings Breakdown

Latest BRKR, TXG, AVTR, and PKI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
10x Genomics stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
6/26/2025
Bruker Corporation stock logo
BRKR
Bruker
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$61.00 ➝ $50.00
6/26/2025
10x Genomics stock logo
TXG
10x Genomics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$12.00 ➝ $13.00
6/24/2025
10x Genomics stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$12.00 ➝ $13.00
6/11/2025
10x Genomics stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
5/24/2025
10x Genomics stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
5/22/2025
Bruker Corporation stock logo
BRKR
Bruker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold$50.00 ➝ $40.00
5/19/2025
10x Genomics stock logo
TXG
10x Genomics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$26.00 ➝ $18.00
5/15/2025
10x Genomics stock logo
TXG
10x Genomics
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$14.00 ➝ $14.00
5/13/2025
10x Genomics stock logo
TXG
10x Genomics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$14.00 ➝ $12.00
5/12/2025
10x Genomics stock logo
TXG
10x Genomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$7.50 ➝ $6.50
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.78B1.36$1.61 per share8.41$8.75 per share1.55
Bruker Corporation stock logo
BRKR
Bruker
$3.45B1.84$3.59 per share11.64$11.85 per share3.53
Revvity, Inc. stock logo
PKI
Revvity
$3.31B0.00N/A9.88$58.49 per share0.00
10x Genomics stock logo
TXG
10x Genomics
$610.78M2.36N/AN/A$5.81 per share2.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
$711.50M$1.0413.0311.291.4410.70%11.93%5.50%7/25/2025 (Estimated)
Bruker Corporation stock logo
BRKR
Bruker
$113.10M$0.5280.3813.272.812.31%19.47%5.95%8/5/2025 (Estimated)
Revvity, Inc. stock logo
PKI
Revvity
$569.18M$7.6815.010.000.5028.94%11.17%5.83%N/A
10x Genomics stock logo
TXG
10x Genomics
-$182.63M-$1.30N/AN/AN/A-25.14%-23.22%-18.02%8/6/2025 (Estimated)

Latest BRKR, TXG, AVTR, and PKI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/25/2025Q2 2025
Avantor, Inc. stock logo
AVTR
Avantor
$0.25N/AN/AN/A$1.67 billionN/A
5/8/2025Q1 2025
10x Genomics stock logo
TXG
10x Genomics
-$0.45-$0.36+$0.09-$0.28$131.91 million$154.88 million
5/7/2025Q1 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.46$0.47+$0.01$0.11$763.83 million$801.40 million
4/25/2025Q1 2025
Avantor, Inc. stock logo
AVTR
Avantor
$0.23$0.23N/A$0.09$1.61 billion$1.58 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Bruker Corporation stock logo
BRKR
Bruker
$0.200.48%N/A38.46%N/A
Revvity, Inc. stock logo
PKI
Revvity
$0.280.24%N/A3.65%N/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest BRKR, TXG, AVTR, and PKI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/12/2025
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.5%6/16/20256/16/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
0.54
1.12
0.75
Bruker Corporation stock logo
BRKR
Bruker
1.13
1.57
0.74
Revvity, Inc. stock logo
PKI
Revvity
0.48
2.43
2.15
10x Genomics stock logo
TXG
10x Genomics
N/A
5.37
4.68

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Bruker Corporation stock logo
BRKR
Bruker
79.52%
Revvity, Inc. stock logo
PKI
Revvity
85.22%
10x Genomics stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
1.20%
Bruker Corporation stock logo
BRKR
Bruker
27.30%
Revvity, Inc. stock logo
PKI
Revvity
0.52%
10x Genomics stock logo
TXG
10x Genomics
10.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
13,500681.43 million673.25 millionOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,396151.53 million110.16 millionOptionable
Revvity, Inc. stock logo
PKI
Revvity
16,700126.41 million125.76 millionOptionable
10x Genomics stock logo
TXG
10x Genomics
1,240123.13 million110.78 millionOptionable

Recent News About These Companies

10x Genomics (NASDAQ:TXG) Downgraded by Wall Street Zen to Hold
10x Genomics (NASDAQ:TXG) Trading 7.3% Higher Following Analyst Upgrade
10x Genomics: Stuck In Neutral
10x Genomics Settles Patent Dispute With Bruker

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avantor stock logo

Avantor NYSE:AVTR

$13.52 -0.01 (-0.10%)
As of 09:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Bruker stock logo

Bruker NASDAQ:BRKR

$41.25 -0.55 (-1.32%)
As of 09:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Revvity stock logo

Revvity NYSE:PKI

Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$11.83 +0.10 (+0.85%)
As of 09:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.